Skip to main content
. 2012 Dec 28;7(Suppl 1):76–80. doi: 10.1111/irv.12049

Figure 1.

Figure 1

 Influenza antiviral drugs approved in the United States or under development in 2006 (A) or 2011 (B). The compounds are indicated by name with the company sponsoring their development. Route of administration is indicated based on the color scheme shown in the legend. The drugs were categorized based on their mechanism of action and stage of development in the United States.